标题
Evolution of care for patients with relapsed glioblastoma
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume 11, Issue 11, Pages 1719-1729
出版商
Informa UK Limited
发表日期
2011-11-03
DOI
10.1586/era.11.152
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
- (2011) D.-S. Kong et al. NEURO-ONCOLOGY
- A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
- (2011) Teri N. Kreisl et al. NEURO-ONCOLOGY
- Improvement, Clinical Course, and Quality of Life After Palliative Radiotherapy for Recurrent Glioblastoma
- (2010) Carsten Nieder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
- (2010) Michael Brada et al. JOURNAL OF CLINICAL ONCOLOGY
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
- (2010) John K. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
- (2010) A. B. Heimberger et al. NEURO-ONCOLOGY
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
- (2009) D A Reardon et al. BRITISH JOURNAL OF CANCER
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging
- (2009) Jennifer L. Clarke et al. Current Neurology and Neuroscience Reports
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
- (2009) Amy B Heimberger et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
- (2009) Walid S. Kamoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- The Hardest Job in Medicine
- (2009) Richard C. Frank JOURNAL OF CLINICAL ONCOLOGY
- Reply to A. Garcia et al
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Living With Imperfection
- (2009) Tony S.K. Mok JOURNAL OF CLINICAL ONCOLOGY
- Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
- (2009) Gregor Dresemann et al. JOURNAL OF NEURO-ONCOLOGY
- Extended-schedule dose-dense temozolomide in refractory gliomas
- (2009) A. Berrocal et al. JOURNAL OF NEURO-ONCOLOGY
- The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry
- (2009) Adelheid Wöhrer et al. JOURNAL OF NEURO-ONCOLOGY
- Rechallenge with temozolomide in patients with recurrent gliomas
- (2009) Antje Wick et al. JOURNAL OF NEUROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- BEVACIZUMAB FOR RECURRENT MALIGNANT GLIOMAS: EFFICACY, TOXICITY, AND PATTERNS OF RECURRENCE
- (2009) M. C. Chamberlain et al. NEUROLOGY
- Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience
- (2008) Silvia Scoccianti et al. ANTI-CANCER DRUGS
- ‘Recurrent’ glioblastoma multiforme, when should we reoperate?
- (2008) Giuseppe M. V. Barbagallo et al. BRITISH JOURNAL OF NEUROSURGERY
- Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
- (2008) Casilda Balmaceda et al. CANCER
- Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule
- (2008) James R. Perry et al. CANCER
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
- (2008) Eric Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
- (2008) Maria Grazia Fabrini et al. JOURNAL OF NEURO-ONCOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now